Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Biomedical Research|May 31, 2013
Effect of EME1 exon variant Ile350Thr on risk and early onset of breast cancer in southern Chinese womenJianwei Zhao, Lin Liu, Anqing Zhang, et al.Journal of Advanced Research|May 22, 2026
A triple-functional sandwich-like nanofibrous matrix for accelerated gingival augmentationLizhi Zeng, Shanghui Huang, Tim Forouzanfar, et al.Cancer|March 13, 2010
A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acidPeter E Zage, Lizhi Zeng, Shana Palla, et al.Materials Today. Bio|August 1, 2025
Self-propelled gas nanomotor-integrated microneedles for melanoma therapy: Dual-action in situ eradication and metastatic suppressionChungchi Lee, Shanghui Huang, Huiling Liu, et al.Cancer|October 21, 2010
The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecanPeter E Zage, Timothy C Graham, Lizhi Zeng, et al.Investigational New Drugs|October 5, 2010
The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastomaAlejandro G Levy, Peter E Zage, Lauren J Akers, et al.Molecular Cancer Therapeutics|June 11, 2009
Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathwayKenneth Thress, Terry Macintyre, Haiyun Wang, et al.Gastroenterology|January 14, 2012
Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cellsMaria I Almeida, Milena S Nicoloso, Lizhi Zeng, et al.Pageof 1